Awada, A, Ochsenreither, S, Eefsen, R L, Arnold, D, Yachnin, J, Pfeiffer, P, Jungels, C, Greil, R, Poulsen, L, Van Cutsem, E, Thorsson, L, Svedman, C, Garcia-Ribas, I & Collignon, J 2021, ' Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer. Journal of Clinical Oncology ', Journal of Clinical Oncology, vol. 39, no. Suppl. 15, e16228 . https://doi.org/10.1200/JCO.2021.39.15_suppl.e16228 Awada, A, Ochsenreither, S, Eefsen, R L, Arnold, D, Yachnin, J, Pfeiffer, P, Jungels, C, Greil, R, Poulsen, L, Van Cutsem, E, Thorsson, L, Svedman, C, Garcia-Ribas, I & Collignon, J 2021, ' Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer. Journal of Clinical Oncology ', Journal of Clinical Oncology, vol. 39, no. 15. suppl, e16228 . https://doi.org/10.1200/JCO.2021.39.15_suppl.e16228